Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Cantor Fitzgerald
Baxter
Merck
Covington
Daiichi Sankyo
Boehringer Ingelheim
Argus Health
QuintilesIMS
Healthtrust

Generated: August 16, 2017

DrugPatentWatch Database Preview

Potassium acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for potassium acetate and what is the scope of potassium acetate patent protection?

Potassium acetate
is the generic ingredient in one branded drug marketed by Exela Pharma Scs Llc and Hospira, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two hundred and twenty-eight drug master file entries for potassium acetate. Two suppliers are listed for this compound.

Summary for Generic Name: potassium acetate

Tradenames:1
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list228
Suppliers / Packagers: see list2
Bulk Api Vendors: see list71
Clinical Trials: see list1,504
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:potassium acetate at DailyMed

Pharmacology for Ingredient: potassium acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
POTASSIUM ACETATE
potassium acetate
INJECTABLE;INJECTION018896-001Jul 20, 1984APRXYesYes► Subscribe► Subscribe► Subscribe
Exela Pharma Scs Llc
POTASSIUM ACETATE
potassium acetate
INJECTABLE;INJECTION206203-001Dec 29, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Harvard Business School
Cantor Fitzgerald
QuintilesIMS
Fuji
AstraZeneca
Queensland Health
Daiichi Sankyo
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot